/Investor DB

Matū

Venture capital

Auckland · Pre-Seed–Seed · 24 people tracked

Find your way into Matū

Sign up to see every warm intro you have to Matū

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Matū team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Matū operates venture capital funds focused on science and deep tech companies in Aotearoa New Zealand. It takes a hands-on, active approach, backing researchers and founders working on real-world solutions to global challenges. The firm aims to turn ground-breaking scientific ideas into globally focused, IP-rich companies, drawing on decades of combined commercial and scientific experience. Portfolio companies receive strong governance, strategy, IP, and capital-raising expertise, plus access to domain experts connected to the global scientific and academic community. Matū frequently syndicates investments alongside other professional investors to reduce risk and broaden networks.

Source: firm website, verified Sep 27, 2026.

Stage
Pre-Seed–Seed
HQ
Auckland, NZ
Instruments
Equity
Tracked investments
20

Team · 24 people

from the firm's website

What they invest in

from 8 of 20 portfolio companies

Biotech ×4Healthtech ×4AI & Machine Learning ×2Cleantech ×2Deep Tech ×2Medical Devices ×2New Materials ×2Climate Tech ×1

HQs:New Zealand×5Australia×1United States×1

Investments · 20 tracked

founders shown can be your intro path
Advemtoadvemto.comin

Advemto maps complex cell function to genetic sequences at scale without requiring new laboratory instruments.

BiotechDeep Tech

Co-investorsBooster Innovation FundEnterprise AngelsNuance CapitalNZ Growth Capital Partners

Alimetryalimetry.comin𝕏

Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms.

AI & Machine LearningDigital HealthHealthtechMedical DevicesAuckland, NZ

Greg O'Grady(Founder)inArmen Gharibans(Founder)inKaren O'Regan(CBO)inCraig Shannon(CTO)inChristie Dunwoodie(CFO)inChristopher Andrews(CMO)

Co-investorsBooster Innovation FundCerity Partners VenturesGD1MovacOlympus Innovation VenturesIcehouse Ventures+1 more

Ferronovaferronova.com.auin

Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic.

BiotechHealthtechMedical Devices

Benjamin Thierry(Scientific Advisor/Founder)inStewart Bartlett(CEO)inAnil Shetty(CMO)in

Co-investorsArtesianSouth Australian Venture Capital FundBooster Innovation FundStoic VCUniSeed Pty Ltd.

Inhibit Coatingsinhibitcoatings.comin

Inhibit Coatings develops antimicrobial coatings and additives that use silver permanently bound to polymer resin to inhibit bacterial growth without leaching.

CleantechHealthtechNew MaterialsWellington, NZ

Dr Tate(Co-creator of the technology)Prof. Johnston(Co-creator of the technology)

Co-investorsAngel HQArc AngelsBooster Innovation FundEnterprise AngelsIcehouse VenturesNZ Growth Capital Partners

Liquiumliquium.nz

Liquium develops a new catalyst technology for producing clean (zero-carbon) ammonia under milder operating conditions than the traditional Haber-Bosch process, aiming to lower production and operating costs.

CleantechClimate TechNew Materials

Dr Franck Natali(CSO & Co-Founder)Dr Paul Geraghty(CEO & Co-Founder)

Co-investorsBooster Innovation FundClimate Venture Capital Fund

Opo Bioopobio.comin𝕏

Opo develops bio-based ingredients and cell lines for cosmetic, medical, and cultivated meat applications using synthetic biology and biomanufacturing.

BiotechDeep TechFoodTechAuckland, NZ

Co-investorsBooster Innovation FundWNT VenturesEpic Angels

PowerONpoweron.one

Commercialising soft electronics technology for robotics applications.

Co-investorsBooster Innovation FundNZ Growth Capital PartnersPacific Channel

Roster Labrosterlab.comin

RosterLab provides AI-powered staff scheduling software that automates the creation of complex work rosters for healthcare and other organizations.

AI & Machine LearningEnterprise SoftwareHealthtechHR TechSaaSAuckland, NZ

IsaacDanielSunny

Co-investorsMovacPacific ChannelQuidnet Ventures

Synthase Biotech Ltdsynthasebiotech.com

Early-stage company commercialising the Aloxsyn® enzyme technology that prevents and repairs lipid oxidation damage in cell membranes, initially applied to livestock fertility (AI and IVF) with broader potential in human fertility and food/beverage shelf life.

Co-investorsNZ Growth Capital Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AmaeaAmpersand TechnologiesCaptivateCAS (Codify Asset Solutions)CAS (Codify Solutions)ChitogelCodify Asset SolutionsHtsHTS-110MEKONOSRekover Therapeutics

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Matū made?
Matū has 20 tracked investments.
What stage does Matū invest at?
Matū invests at the Pre-Seed, Seed stages.
What sectors does Matū focus on?
Matū focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Deep Tech, Medical Devices, New Materials.
Where is Matū located?
Matū is headquartered in Auckland, NZ.
Who does Matū co-invest with?
Matū most often shares deals with Booster Innovation Fund, NZ Growth Capital Partners, Enterprise Angels, among 22 tracked co-investors.

Images

Matū photo

Similar investors

Featured in lists